As of 2025-07-10, the Relative Valuation of Simcere Pharmaceutical Group Ltd (2096.HK) is 8.06 HKD. This relative valuation is based on P/E multiples. With the latest stock price at 10.70 HKD, the upside of Simcere Pharmaceutical Group Ltd based on Relative Valuation is -24.7%.
The range of the Relative Valuation is 6.87 - 9.21 HKD.
| Range | Selected | |
| Trailing P/E multiples | 23.4x - 28.5x | 26.1x |
| Forward P/E multiples | 17.1x - 20.7x | 19.2x |
| Fair Price | 6.87 - 9.21 | 8.06 |
| Upside | -35.8% - -14.0% | -24.7% |
| Date | P/E |
| 2025-07-03 | 284.79 |
| 2025-07-02 | 274.09 |
| 2025-06-30 | 270.21 |
| 2025-06-27 | 267.29 |
| 2025-06-26 | 268.26 |
| 2025-06-25 | 267.78 |
| 2025-06-24 | 274.58 |
| 2025-06-23 | 272.64 |
| 2025-06-20 | 260.00 |
| 2025-06-19 | 245.91 |
| 2025-06-18 | 263.89 |
| 2025-06-17 | 260.97 |
| 2025-06-16 | 291.59 |
| 2025-06-13 | 299.36 |
| 2025-06-12 | 311.03 |
| 2025-06-11 | 298.88 |
| 2025-06-10 | 296.93 |
| 2025-06-09 | 312.97 |
| 2025-06-06 | 303.25 |
| 2025-06-05 | 297.91 |
| 2025-06-04 | 303.74 |
| 2025-06-03 | 296.45 |
| 2025-06-02 | 302.77 |
| 2025-05-30 | 312.00 |
| 2025-05-29 | 296.45 |
| 2025-05-28 | 265.35 |
| 2025-05-27 | 268.75 |
| 2025-05-26 | 246.88 |
| 2025-05-23 | 251.25 |
| 2025-05-22 | 251.25 |
| 2025-05-21 | 253.68 |
| 2025-05-20 | 238.62 |
| 2025-05-19 | 229.63 |
| 2025-05-16 | 211.89 |
| 2025-05-15 | 204.11 |
| 2025-05-14 | 205.08 |
| 2025-05-13 | 203.14 |
| 2025-05-12 | 200.22 |
| 2025-05-09 | 215.78 |
| 2025-05-08 | 211.89 |
| 2025-05-07 | 209.46 |
| 2025-05-06 | 217.96 |
| 2025-05-02 | 218.45 |
| 2025-04-30 | 212.86 |
| 2025-04-29 | 212.13 |
| 2025-04-28 | 210.19 |
| 2025-04-25 | 207.27 |
| 2025-04-24 | 213.83 |
| 2025-04-23 | 212.37 |
| 2025-04-22 | 208.00 |